glp-1 supply news november 2025 Agonists Weight Loss Drugs Market Report, 2025-2030 2025 dominates for GLP-1 trial

Here are the deets on deficiency plus some delish B12-rich foods to add to your diet

Glutathione, in fact, is the only vitamin that has been proven to be effective in treating all of these skin conditions

Advisory Board research predicts a 22% decline in bariatric surgery by 2029

It does not require a weekly confrontation with a needle

It can be taken with or without food, though a high-fat meal may delay its effectiveness

Tirzepatide, the active ingredient in Mounjaro and Zepbound, is a 39-amino acid dual agonist targeting both GLP-1 and GIP receptors, also incorporating a fatty acid modification for half-life extension, and is the most commercially significant synthetic peptide ever produced at scale